Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Postoperative Complications

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Postoperative Complications in 1 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoff, U1
Bubalo, G1
Fechner, M1
Blum, M1
Zhu, Y1
Pohlmann, A1
Hentschel, J1
Arakelyan, K1
Seeliger, E1
Flemming, B1
Gürgen, D1
Rothe, M1
Niendorf, T1
Manthati, VL1
Falck, JR1
Haase, M1
Schunck, WH1
Dragun, D1

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Postoperative Complications

ArticleYear
A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.
    Acta physiologica (Oxford, England), 2019, Volume: 227, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Acute Kidney Injury; Animals; Cardiac Surgical Procedures; Fatty Acids;

2019